"Because of the risk of opioid addiction, misuse and abuse, Dsuvia is also intended for patients who have not tolerated alternative pain management options or whose tolerability is unlikely, if existing treatment options are not contemplated adequate analgesia or if any of these alternatives no adequate analgesia is expected, "says a statement by Gottlieb on the approval of the drug.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.